Cathie Wood’s ARK ETFs shuffle tech and health stocks

Published 02/05/2025, 01:06
© REUTERS

Cathie Wood’s ARK ETF published their daily trades for Thursday, May 1st, 2025, revealing a series of strategic moves across the technology and healthcare sectors. Leading the trades was a significant investment in Robinhood Markets Inc (NASDAQ:HOOD), with ARK’s flagship ARKK ETF purchasing 210,714 shares valued at approximately $10.3 million. This move underscores ARK’s ongoing confidence in the fintech company, despite the volatility in the market.

Another major buy for the day was Guardant Health Inc (NASDAQ:GH), with 186,812 shares added to the ARKK ETF, amounting to a hefty investment of over $8.8 million. This trade aligns with ARK’s focus on innovative companies in the healthcare space, particularly those involved in precision medicine and diagnostics.

Advanced Micro Devices Inc (NASDAQ:AMD) also saw a boost from ARK, with a combined purchase of 29,228 shares through the ARKK and ARKW ETFs, totaling around $2.8 million. This buy adds to ARK’s recent accumulation of AMD stock, indicating a bullish stance on the semiconductor industry and AMD’s growth prospects.

In the autonomous technology and robotics sector, ARK’s ARKQ ETF bought 184,742 shares of Aurora Innovation Inc (NASDAQ:AUR) valued at approximately $1.3 million. ARK’s investment in Aurora Innovation reflects a bet on the future of self-driving technology.

On the sell side, ARK continued to trim its holdings in defense contractor Kratos Defense and Security Solutions Inc (NASDAQ:KTOS), with the ARKQ ETF parting with 37,591 shares for a total of about $1.2 million. The divestment follows a pattern of sales in Kratos stock over recent days.

Data analytics firm Palantir Technologies Inc (NYSE:NASDAQ:PLTR) also saw a reduction, with ARKK ETF selling 19,406 shares, amounting to nearly $2.3 million. Similarly, gaming platform Roblox Corp (NYSE:RBLX) was on the selling block with 49,969 shares sold by the ARKK ETF, totaling over $3.3 million.

The ARKK ETF also sold 87,765 shares of Veracyte Inc (NASDAQ:VCYT), a genomic diagnostics company, for about $2.7 million. This continues a trend of ARK offloading Veracyte stock observed in the past week.

Other notable trades included purchases of Blade Air Mobility Inc (NASDAQ:BLDE), GitLab Inc (NASDAQ:GTLB), Pacific Biosciences of California Inc (NASDAQ:PACB), Personalis Inc (NASDAQ:PSNL), Shopify Inc (NYSE:NASDAQ:SHOP), and 10X Genomics Inc (NASDAQ:TXG), as well as minor sales of UiPath Inc (NYSE:PATH).

Investors following ARK’s trades can discern a pattern of bolstering positions in companies with disruptive technologies and innovative healthcare solutions while adjusting holdings in defense, data analytics, and gaming sectors. These trades offer insights into the investment firm’s strategy and market outlook, providing a glimpse into the potential future of these dynamic industries.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.